State policy variations related to these plans could have significant impacts on the overall insurance market. Here’s what you need to know.
When insurers stopped receiving cost-sharing reduction payments from the government last year, many significantly upped premiums for certain health plans. Here’s more on why they did it, what they did, and six things healthcare executives should know.
The law opens up new options for terminally ill patients. But how will it impact managed care organizations?
Healthcare experts weigh in on the president’s plan to lower drug prices. Here’s what they said.
Preparing for pharmacy policy changes can help your managed care organization stay ahead of the competition. Here, pharmacy experts highlight three areas to watch closely.
Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications
New research shows that health insurers won’t be able to curb costs and improve outcomes through accountable care organizations (ACOs). At least, they won’t be able to realize savings any time soon.
The conditions that are the biggest drivers of female mortality, some preventive measures, and the latest treatment advances.
For the first time, Managed Healthcare Executive has selected 10 emerging healthcare industry leaders, working in the areas of pharmacy, health plans, health systems, and technology.
The goal is to help ensure that prescription drug marketing information for consumers and healthcare providers is truthful and balanced. Here’s what the agency plans to research.